The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.

NPJ Breast Cancer 2017 9;3:22. Epub 2017 Jun 9.

Department of Health Sciences Research, Mayo Clinic, Rochester, MN USA.

Understanding the gene-specific risks for development of breast cancer will lead to improved clinical care for those carrying germline mutations in cancer predisposition genes. We sought to detail the spectrum of mutations and refine risk estimates for known and proposed breast cancer susceptibility genes. Targeted massively-parallel sequencing was performed to identify mutations and copy number variants in 26 known or proposed breast cancer susceptibility genes in 2134 negative women with familial breast cancer (proband with breast cancer and a family history of breast or ovarian cancer) from a largely European-Caucasian multi-institutional cohort. Case-control analysis was performed comparing the frequency of internally classified mutations identified in familial breast cancer women to Exome Aggregation Consortium controls. Mutations were identified in 8.2% of familial breast cancer women, including mutations in high-risk (odds ratio > 5) (1.4%) and moderate-risk genes (2 < odds ratio < 5) (2.9%). The remaining familial breast cancer women had mutations in proposed breast cancer genes (1.7%), Lynch syndrome genes (0.5%), and six cases had two mutations (0.3%). Case-control analysis demonstrated associations with familial breast cancer for , and mutations (odds ratio > 3.0,  < 10), mutations (odds ratio = 3.2,  = 0.012), and truncating mutations (odds ratio1.6,  = 0.041). Our results demonstrate that approximately 4.7% of negative familial breast cancer women have mutations in genes statistically associated with breast cancer. We classified and as high-risk, and as moderate risk, and truncating mutations as low risk breast cancer predisposition genes. This study demonstrates that large case-control studies are needed to fully evaluate the breast cancer risks associated with mutations in moderate-risk and proposed susceptibility genes.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41523-017-0024-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466608PMC
June 2017
82 Reads

Article Mentions


Provided by Crossref Event Data
twitter
Twitter: OlivierBranford
September 26, 2018, 4:19 pm EST
twitter
Twitter: Chrisvsbiologic
July 25, 2018, 5:42 am EST
twitter
Twitter: Breastguide
July 25, 2018, 5:39 am EST
twitter
Twitter: Nfanget
August 7, 2017, 10:20 am EST
twitter
Twitter: BioGibberish
August 7, 2017, 7:46 am EST
twitter
Twitter: Nature_NPJ
June 16, 2017, 6:00 am EST
twitter
Twitter: OncoGenetPeru
June 13, 2017, 10:45 pm EST
twitter
Twitter: Bemygene
June 12, 2017, 7:15 am EST
twitter
Twitter: ChpHealthcare
June 9, 2017, 5:06 am EST
twitter
Twitter: ChpHealthcare
June 9, 2017, 5:06 am EST

Publication Analysis

Top Keywords

breast cancer
36
familial breast
16
susceptibility genes
12
cancer susceptibility
12
cancer
11
breast
10
cancer women
8
mutations identified
8
proposed breast
8
mutations
6
genes
5
family history
4
proband breast
4
cancer family
4
cancer european-caucasian
4
breast ovarian
4
ovarian cancer
4
cancer proband
4
history breast
4
european-caucasian multi-institutional
4

References

(Supplied by CrossRef)
Article in Cancer J. Clin.
JN Weitzel et al.
Cancer J. Clin. 2011
Article in J. Clin. Oncol.
MA Blackwood et al.
J. Clin. Oncol. 1998
Article in Cell
AR Venkitaraman et al.
Cell 2002
Article in N. Engl. J. Med.
DF Easton et al.
N. Engl. J. Med. 2015
Article in Cancer
N Tung et al.
Cancer 2015
Article in Genet. Med.
H LaDuca et al.
Genet. Med. 2014
Article in Clin. Genet.
C Cybulski et al.
Clin. Genet. 2015
Article in J. Med. Genet.
J Li et al.
J. Med. Genet. 2016
Article in FEBS J.
F Aloraifi et al.
FEBS J. 2015
Article in Int. J. Cancer
C Kraus et al.
Int. J. Cancer 2016
Article in J. Clin. Oncol.
N Tung et al.
J. Clin. Oncol. 2012

Similar Publications